This disclosure relates to methods of use related to omega-3 very-long-chain polyunsaturated fatty acids (n-3 VLC-PUFA) and their hydroxylated derivatives known as elovanoids to alleviate a symptom of, treat, or prevent disease. Furthermore, this invention is directed to compositions and methods for modulating VLC-PUFA bioactivity and availability.
本公开涉及使用方法与ω-3非常长链多不饱和
脂肪酸(n-3 VLC-PUFA)及其羟基化衍
生物(称为elovanoids)缓解症状、治疗或预防疾病。此外,本发明还涉及调节VLC-PUFA
生物活性和可用性的组合物和方法。